Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Binance sees $956 million in outflows after Zhao steps down to settle US probe
Post Content Post Views: 124
Bonds enjoy Fed rate cuts talk
Post Content Post Views: 121
Gene editing stocks slide after two-day rally
Post Content Post Views: 122
First Quantum’s Panama mine not operating at commercial production levels
Post Content Post Views: 106
Black Friday shoppers spent a record $9.8 billion in U.S. online sales, up 7.5% from last year
Black Friday kept the momentum going from the day before on Thanksgiving when online sales totaled $5.6 billion. Post Views: 112
Best Buy flags weakening consumer demand heading into holiday shopping season
Post Content Post Views: 112